![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
X Peng, M Katz, V Gerzanich, R Anand and J Lindstrom
Department of Neuroscience, University of Pennsylvania Medical School, Philadelphia 19104-6074.
The alpha-bungarotoxin-binding acetylcholine receptors from the human neuroblastoma cell line SH-SY5Y were found to cross-react with some monoclonal antibodies to alpha 7 subunits of nicotinic acetylcholine receptors from chicken brain. The human alpha 7 subunit cDNA from SH- SY5Y was cloned, revealing 94% amino acid sequence identity to rat alpha 7 subunits and 92% identity to chicken alpha 7 subunits. Native human alpha 7 receptors showed affinities for some ligands similar to those previously observed with native chicken alpha 7 receptors, but for other ligands there were large species-specific differences in binding affinity. These results paralleled properties of alpha 7 homomers expressed in Xenopus oocytes. Human alpha 7 homomers exhibited rapidly desensitizing, inwardly rectifying, agonist-induced, cation currents that triggered Ca(2+)-sensitive Cl- channels in the oocytes. A change in efficacy from partial agonist for chicken alpha 7 homomers to full agonist for human alpha 7 homomers was exhibited by 1,1-dimethyl-4- phenylpiperazinium. This result reveals a large species-specific pharmacological difference, despite small differences in alpha 7 sequences. This is important for understanding the effects of these drugs in humans and for identifying amino acids that may contribute to the acetylcholine binding site, for analysis by in vitro mutagenesis. These results also characterize properties of native alpha 7 receptors and alpha 7 homomers that will provide criteria for functional properties expected of structural subunits, when these can be identified, cloned, and coexpressed with alpha 7 subunits.
This article has been cited by other articles:
|
|
 |
|
  L. Tapia, A. Kuryatov, and J. Lindstrom Ca2+ Permeability of the ({alpha}4)3(beta2)2 Stoichiometry Greatly Exceeds That of ({alpha}4)2(beta2)3 Human Acetylcholine Receptors Mol. Pharmacol., March 1, 2007; 71(3): 769 - 776. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Gaibelet, T. Planchenault, S. Mazeres, F. Dumas, F. Arenzana-Seisdedos, A. Lopez, B. Lagane, and F. Bachelerie CD4 and CCR5 Constitutively Interact at the Plasma Membrane of Living Cells: A CONFOCAL FLUORESCENCE RESONANCE ENERGY TRANSFER-BASED APPROACH J. Biol. Chem., December 8, 2006; 281(49): 37921 - 37929. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. van Nierop, S. Bertrand, D. W. Munno, Y. Gouwenberg, J. van Minnen, J. D. Spafford, N. I. Syed, D. Bertrand, and A. B. Smit Identification and Functional Expression of a Family of Nicotinic Acetylcholine Receptor Subunits in the Central Nervous System of the Mollusc Lymnaea stagnalis J. Biol. Chem., January 20, 2006; 281(3): 1680 - 1691. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Charpantier, A. Wiesner, K.-H. Huh, R. Ogier, J.-C. Hoda, G. Allaman, M. Raggenbass, D. Feuerbach, D. Bertrand, and C. Fuhrer {alpha}7 Neuronal Nicotinic Acetylcholine Receptors Are Negatively Regulated by Tyrosine Phosphorylation and Src-Family Kinases J. Neurosci., October 26, 2005; 25(43): 9836 - 9849. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-H. Peng, J. D. Fryer, R. S. Hurst, K. M. Schroeder, A. A. George, S. Morrissy, V. E. Groppi, S. S. Leonard, and R. J. Lukas High-Affinity Epibatidine Binding of Functional, Human {alpha}7-Nicotinic Acetylcholine Receptors Stably and Heterologously Expressed de Novo in Human SH-EP1 Cells J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 24 - 35. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Williams, B. Burton, A. Urrutia, A. Shcherbatko, L. E. Chavez-Noriega, C. J. Cohen, and J. Aiyar Ric-3 Promotes Functional Expression of the Nicotinic Acetylcholine Receptor {alpha}7 Subunit in Mammalian Cells J. Biol. Chem., January 14, 2005; 280(2): 1257 - 1263. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. G. Severance, H. Zhang, Y. Cruz, S. Pakhlevaniants, S. H. Hadley, J. Amin, L. Wecker, C. Reed, and J. Cuevas The {alpha}7 Nicotinic Acetylcholine Receptor Subunit Exists in Two Isoforms that Contribute to Functional Ligand-Gated Ion Channels Mol. Pharmacol., September 1, 2004; 66(3): 420 - 429. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. A. Dajas-Bailador, K. Heimala, and S. Wonnacott The Allosteric Potentiation of Nicotinic Acetylcholine Receptors by Galantamine Is Transduced into Cellular Responses in Neurons: Ca2+ Signals and Neurotransmitter Release. Mol. Pharmacol., November 1, 2003; 64(5): 1217 - 1226. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Zhao, Y.-P. Kuo, A. A. George, J.-H. Peng, M. S. Purandare, K. M. Schroeder, R. J. Lukas, and J. Wu Functional Properties of Homomeric, Human {alpha}7-Nicotinic Acetylcholine Receptors Heterologously Expressed in the SH-EP1 Human Epithelial Cell Line J. Pharmacol. Exp. Ther., June 1, 2003; 305(3): 1132 - 1141. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ferreira, S. N. Ebert, D. C. Perry, R. P. Yasuda, C. M. Baker, M. I. Dávila-García, K. J. Kellar, and R. A. Gillis Evidence of a Functional alpha 7-Neuronal Nicotinic Receptor Subtype Located on Motoneurons of the Dorsal Motor Nucleus of the Vagus J. Pharmacol. Exp. Ther., April 13, 2001; 296(2): 260 - 269. [Abstract] [Full Text]
|
|
|
|
|
|
K. T. Dineley and J. W. Patrick Amino Acid Determinants of alpha 7 Nicotinic Acetylcholine Receptor Surface Expression J. Biol. Chem., April 28, 2000; 275(18): 13974 - 13985. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. G. V. Sharples, S. Kaiser, L. Soliakov, M. J. Marks, A. C. Collins, M. Washburn, E. Wright, J. A. Spencer, T. Gallagher, P. Whiteaker, et al. UB-165: A Novel Nicotinic Agonist with Subtype Selectivity Implicates the alpha 4beta 2* Subtype in the Modulation of Dopamine Release from Rat Striatal Synaptosomes J. Neurosci., April 15, 2000; 20(8): 2783 - 2791. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Alkondon, E. F. R. Pereira, H. M. Eisenberg, and E. X. Albuquerque Nicotinic Receptor Activation in Human Cerebral Cortical Interneurons: a Mechanism for Inhibition and Disinhibition of Neuronal Networks J. Neurosci., January 1, 2000; 20(1): 66 - 75. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Palma, S. Fucile, B. Barabino, R. Miledi, and F. Eusebi Strychnine activates neuronal alpha 7 nicotinic receptors after mutations in the leucine ring and transmitter binding site domains PNAS, November 9, 1999; 96(23): 13421 - 13426. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Rakhilin, R. C. Drisdel, D. Sagher, D. S. McGehee, Y. Vallejo, and W. N. Green {alpha}-Bungarotoxin Receptors Contain {alpha}7 Subunits in Two Different Disulfide-bonded Conformations J. Cell Biol., July 12, 1999; 146(1): 203 - 218. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Matsubayashi, M. Alkondon, E. F. R. Pereira, K. L. Swanson, and E. X. Albuquerque Strychnine: A Potent Competitive Antagonist of alpha -Bungarotoxin-Sensitive Nicotinic Acetylcholine Receptors In Rat Hippocampal Neurons J. Pharmacol. Exp. Ther., March 1, 1998; 284(3): 904 - 913. [Abstract] [Full Text]
|
|
|
|
|
|
K. A. Stauderman, L. S. Mahaffy, M. Akong, G. Veliçelebi, L. E. Chavez-Noriega, J. H. Crona, E. C. Johnson, K. J. Elliott, A. Gillespie, R. T. Reid, et al. Characterization of Human Recombinant Neuronal Nicotinic Acetylcholine Receptor Subunit Combinations alpha 2beta 4, alpha 3beta 4 and alpha 4beta 4 Stably Expressed in HEK293 Cells J. Pharmacol. Exp. Ther., February 1, 1998; 284(2): 777 - 789. [Abstract] [Full Text]
|
|
|
|
|
|
R. M. Krause, B. Buisson, S. Bertrand, P.-J. Corringer, J.-L. Galzi, J.-P. Changeux, and D. Bertrand Ivermectin: A Positive Allosteric Effector of the alpha 7 Neuronal Nicotinic Acetylcholine Receptor Mol. Pharmacol., February 1, 1998; 53(2): 283 - 294. [Abstract] [Full Text]
|
|
|
|
|
|
F. Olale, V. Gerzanich, A. Kuryatov, F. Wang, and J. Lindstrom Chronic Nicotine Exposure Differentially Affects the Function of Human alpha 3, alpha 4, and alpha 7 Neuronal Nicotinic Receptor Subtypes J. Pharmacol. Exp. Ther., November 1, 1997; 283(2): 675 - 683. [Abstract] [Full Text]
|
|
|
|
|
|
F. Rangwala, R. C. Drisdel, S. Rakhilin, E. Ko, P. Atluri, A. B. Harkins, A. P. Fox, and S. B. Salman, and William N. Green Neuronal alpha -Bungarotoxin Receptors Differ Structurally from Other Nicotinic Acetylcholine Receptors J. Neurosci., November 1, 1997; 17(21): 8201 - 8212. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Zwart and H. P. M. Vijverberg Potentiation and Inhibition of Neuronal Nicotinic Receptors by Atropine: Competitive and Noncompetitive Effects Mol. Pharmacol., November 1, 1997; 52(5): 886 - 895. [Abstract] [Full Text]
|
|
|
|
|
|
D. Servent, V. Winckler-Dietrich, H.-Y. Hu, P. Kessler, P. Drevet, D. Bertrand, and A. Menez Only Snake Curaremimetic Toxins with a Fifth Disulfide Bond Have High Affinity for the Neuronal alpha 7 Nicotinic Receptor J. Biol. Chem., September 26, 1997; 272(39): 24279 - 24286. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Criado, E. Dominguez del Toro, C. Carrasco-Serrano, F. I. Smillie, J. M. Juiz, S. Viniegra, and J. J. Ballesta Differential Expression of alpha -Bungarotoxin-Sensitive Neuronal Nicotinic Receptors in Adrenergic Chromaffin Cells: A Role for Transcription Factor Egr-1 J. Neurosci., September 1, 1997; 17(17): 6554 - 6564. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Peng, V. Gerzanich, R. Anand, F. Wang, and J. Lindstrom Chronic Nicotine Treatment Up-Regulates alpha 3 and alpha 7 Acetylcholine Receptor Subtypes Expressed by the Human Neuroblastoma Cell Line SH-SY5Y Mol. Pharmacol., May 1, 1997; 51(5): 776 - 784. [Abstract] [Full Text]
|
|
|
|
|
|
M. Quik, J. Philie, and J. Choremis Modulation of alpha 7 Nicotinic Receptor-Mediated Calcium Influx by Nicotinic Agonists Mol. Pharmacol., March 1, 1997; 51(3): 499 - 506. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Gerzanich, A. Kuryatov, R. Anand, and J. Lindstrom ""Orphan"" alpha 6 Nicotinic AChR Subunit Can Form a Functional Heteromeric Acetylcholine Receptor Mol. Pharmacol., February 1, 1997; 51(2): 320 - 327. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. E. Chavez-Noriega, J. H. Crona, M. S. Washburn, A. Urrutia, K. J. Elliott, and E. C. Johnson Pharmacological Characterization of Recombinant Human Neuronal Nicotinic Acetylcholine Receptors halpha 2beta 2, halpha 2beta 4, halpha 3beta 2, halpha 3beta 4, halpha 4beta 2, halpha 4beta 4 and halpha 7 Expressed in Xenopus Oocytes J. Pharmacol. Exp. Ther., January 1, 1997; 280(1): 346 - 356. [Abstract] [Full Text]
|
|
|
|
|
|
O. Delbono, M. Gopalakrishnan, M. Renganathan, L. M. Monteggia, M. L. Messi, and J. P. Sullivan Activation of the Recombinant Human alpha 7 Nicotinic Acetylcholine Receptor Significantly Raises Intracellular Free Calcium J. Pharmacol. Exp. Ther., January 1, 1997; 280(1): 428 - 438. [Abstract] [Full Text]
|
|
|
|
|
|
B. Buisson, M. Gopalakrishnan, S. P. Arneric, J. P. Sullivan, and D. Bertrand Human alpha 4beta 2 Neuronal Nicotinic Acetylcholine Receptor in HEK 293 Cells: A Patch-Clamp Study J. Neurosci., December 15, 1996; 16(24): 7880 - 7891. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Wang, V. Gerzanich, G. B. Wells, R. Anand, X. Peng, K. Keyser, and J. Lindstrom Assembly of Human Neuronal Nicotinic Receptor alpha 5 Subunits with alpha 3, beta 2, and beta 4 Subunits J. Biol. Chem., July 26, 1996; 271(30): 17656 - 17665. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
